This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 97/2/192    most recent 01.RES.0000174815.10996.08v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by De Souza, A.I. Articles by Rose, M.L. Search for Related Content PubMed PubMed Citation Articles by De Souza, A.I. Articles by Rose, M.L. Related Collections Cell biology/structural biology Other arteriosclerosis CV surgery: coronary artery disease CV surgery: transplantation, ventricular assistance, cardiomyopathy Other Vascular biology

(Circulation Research. 2005;97:192.)
© 2005 American Heart Association, Inc.

Clinical Research

Heat Shock Protein 27 Is Associated With Freedom From Graft Vasculopathy After Human Cardiac Transplantation

A.I. De Souza, R. Wait, A.G. Mitchell, N.R. Banner, M.J. Dunn, M.L. Rose

From Transplant Immunology (A.I.D.S., M.L.R.), National Heart and Lung Institute, Imperial College London, Harefield Hospital, Harefield, Middlesex, UK; Kennedy Institute of Rheumatology Division (R.W.), Faculty of Medicine, Imperial College London, Hammersmith, London, UK; the Department of Cardiology (A.G.M., N.R.B.), Royal Brompton and Harefield NHS Trust, Harefield Hospital, Harefield, Middlesex, UK; and the Proteome Research Centre (M.J.D.), Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Ireland.

Correspondence to M.L. Rose, Transplant Immunology, National Heart and Lung Institute, Imperial College London, Harefield Hospital, Harefield, Middlesex, UB9 6JH, United Kingdom. E-mail marlene.rose{at}imperial.ac.uk

Experimental studies have suggested that protective genes protect allografts from cardiac allograft vasculopathy (CAV), the major complication after cardiac transplantation. Here we have sought to confirm this hypothesis using long-term heart transplant recipients. Twenty-two patients that were 9 years or older after transplant were investigated; 11 of these were without angiographic evidence of CAV; 11 had developed early CAV at 1 to 3 years after transplant. To identify proteins that may act as protectors from CAV, a global proteomic approach was used comparing cardiac biopsies from 12 patients taken within the first 2 weeks after transplant and those taken after 9 years from the same patient. Proteins were separated by 2-D gel-electrophoresis, detected by silver staining, and analyzed using Progenesis software. A particular protein spot was found in 4/6 biopsies from patients without CAV, but absent from 5/6 biopsies from those with CAV (P=0.24); however, quantitative analysis of spot intensity showed a significant difference (0.061±0.05 versus 0.003±0.01, P=0.04). This spot was identified by mass spectrometry and a combination of techniques as a diphosphorylated form of HSP27. Immunohistochemistry of further biopsies not only validated that HSP27 was more abundantly expressed on biopsies without CAV but also showed it to be localized to blood vessels. In contrast, vessels from patients with CAV did not express HSP27 (P=0.028x10^–4). Immunohistochemistry of 12 further early biopsies and nontransplanted heart showed HSP27 to be present in normal blood vessels. These findings suggest that expression of a specific diphosphorylated form of HSP27 is associated with healthy blood vessels; it appears to be lost from vessels of patients with graft vasculopathy.

Key Words: cardiac allograft vasculopathy • heat shock protein 27 • protection • proteomics and transplantation

This article has been cited by other articles:

				K. Rayner, Y.-X. Chen, M. McNulty, T. Simard, X. Zhao, D. J. Wells, J. de Belleroche, and E. R. O'Brien Extracellular Release of the Atheroprotective Heat Shock Protein 27 Is Mediated by Estrogen and Competitively Inhibits acLDL Binding to Scavenger Receptor-A Circ. Res., July 18, 2008; 103(2): 133 - 141. [Abstract] [Full Text] [PDF]

				D. Schmauss and M. Weis Cardiac Allograft Vasculopathy: Recent Developments Circulation, April 22, 2008; 117(16): 2131 - 2141. [Abstract] [Full Text] [PDF]

				I. Kardys, N. Rifai, O. Meilhac, J.-B. Michel, J. L. Martin-Ventura, J. E. Buring, P. Libby, and P. M Ridker Plasma Concentration of Heat Shock Protein 27 and Risk of Cardiovascular Disease: A Prospective, Nested Case-Control Study Clin. Chem., January 1, 2008; 54(1): 139 - 146. [Abstract] [Full Text] [PDF]

				M. L. Rose and M. J. Dunn Letter by Rose and Dunn Regarding Article, "Expression of Heat Shock Protein 27 in Human Atherosclerotic Plaques and Increased Plasma Level of Heat Shock Protein 27 in Patients With Acute Coronary Syndrome" Circulation, May 1, 2007; 115(17): e434 - e434. [Full Text] [PDF]

				H. K. Park, S. W. Bae, M. Y. Park, S. W. Kim, Y.-H. Choi, B.-S. Lee, J. E. Park, Y. H. Ko, S. Kim, D.-I. Kim, et al. Response to Letter Regarding Article, "Expression of Heat Shock Protein 27 in Human Atherosclerotic Plaques and Increased Plasma Level of Heat Shock Protein 27 in Patients With Acute Coronary Syndrome" Circulation, May 1, 2007; 115(17): e435 - e435. [Full Text] [PDF]

				E. McGregor and M. J. Dunn Proteomics of the Heart: Unraveling Disease Circ. Res., February 17, 2006; 98(3): 309 - 321. [Abstract] [Full Text] [PDF]